In NSCLC, mutations within PIK3CA usually affecting the helical binding domain (exon 9, E545K or E542K) or the catalytic subunit (exon 20, H1047R or H1047L), are considered oncogenic and targetable [7, 12-16]. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.